Bioethics News

Gene therapy possibilities for certain heart diseases

Gene therapy possibility , which in general does not have any ethical difficulties

Gene therapy is a therapeutic possibility that will surely have great prospects in the coming years, and which in general does not have any ethical difficulties (unless researchers try to modify germ cells). The use of these techniques stalled for a few years, after some patients who participated in clinical trials using this type of cell therapy died.

Now however, efforts are again being made to try to resolve these difficulties. In relation to this, an article published in Nature Medicine (20; 542-547, 2014) discussed the possibility of using gene therapy to treat heart conditions in patients with Friedreich’s ataxia, a mitochondrial disease characterised by neurological degeneration and hypertrophic cardiomyopathy. At present, there are no effective treatments for the heart defects found in this disease. However, the aforementioned article discusses the development of a gene therapy in whiching it was shown that affected heart cells can recover it, which opens up encouraging therapeutic possibilities in these types of diseases.

La entrada Gene therapy possibilities for certain heart diseases aparece primero en Observatorio de Bioética, UCV.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.